Enhanced sensitivity to alkylating agent in lymphocytes from patients with multiple endocrine neoplasia type 1
- 1 June 2000
- journal article
- clinical trial
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 54, 187s-190s
- https://doi.org/10.1016/s0753-3322(00)80041-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Stable overexpression of MEN1 suppresses tumorigenicity of RASOncogene, 1999
- Premature Centromere Division in Patients with Multiple Endocrine Neoplasia Type 1Cancer Genetics and Cytogenetics, 1999
- Menin Interacts with the AP1 Transcription Factor JunD and Represses JunD-Activated TranscriptionCell, 1999
- Novel MEN1 gene mutations in familial multiple endocrine neoplasia type 1Journal of Human Genetics, 1998
- Multiple Endocrine Neoplasia--Syndromes of the Twentieth CenturyJournal of Clinical Endocrinology & Metabolism, 1998
- Characterization of Mutations in Patients with Multiple Endocrine Neoplasia Type 1American Journal of Human Genetics, 1998
- Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1Human Molecular Genetics, 1997
- Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1Science, 1997
- Chromosomal instability in multiple endocrine neoplasia type 1 cytogenetic evaluation with DEB testCancer Genetics and Cytogenetics, 1995
- Chromosome abnormalities in lymphocytes and fibroblasts of subjects with multiple endocrine neoplasia type 1Cancer Genetics and Cytogenetics, 1991